Document Detail


Renin-Angiotensin system blocker use may be associated with suppression of atrial fibrillation recurrence after pulmonary vein isolation.
MedLine Citation:
PMID:  21091729     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Introduction: An additional approach may be essential to reduce recurrences of atrial fibrillation (AF) after pulmonary vein isolation (PVI). We examined the efficacy of renin-angiotensin system blockers (RAS-B) in suppressing AF recurrences after PVI. Methods and Results: We retrospectively studied 264 consecutive patients (195 male, median age: 63 years) who underwent successful PVI of paroxysmal (n = 94) or persistent AF (n = 170). RAS-B treatment was performed in 145 patients (angiotensin-converting enzyme inhibitors; n = 13, angiotensin receptor blockers; n = 129, both; n = 3). Echocardiography was performed before and 3 months after the ablation to examine the occurrence of left atrial structural reverse remodeling (LA-RR). After a median follow-up of 195 (interquartile range: 95-316) days, AF recurred in 51 (19.3%) patients. A Cox regression analysis revealed that AF recurrence was significantly lower in the patients with RAS-B than in those without (hazard ratio [HR] = 0.41 [95% confidence interval (CI): 0.23-0.71], P = 0.002). After a multivariate adjustment for potential confounders, the use of RAS-B (HR = 0.39 [95% CI: 0.19-0.77], P = 0.007) and type of AF (HR = 0.30 [95% CI: 0.13-0.66], P = 0.003) were the independent predictors for AF recurrence during the entire follow-up. Although effect of RAS-B was not significant during the early follow-up (<3 month), it was the only independent predictor during the late follow-up (>3 months) (HR = 0.21 [95% CI: 0.08-0.53], P = 0.001). There were no significant differences in LA-RR occurrence regarding RAS-B medication. The use of RAS-B was an independent predictor of late AF recurrences irrespective of an early LA-RR occurrence. Conclusions: Treatment with RAS-B significantly reduced the AF recurrence after PVI. This benefit became more prominent 3 months after the PVI. (PACE 2011; 34:296-303).
Authors:
Kiyotake Ishikawa; Takumi Yamada; Yukihiko Yoshida; Masateru Takigawa; Yutaka Aoyama; Natsuo Inoue; Yasushi Tatematsu; Mamoru Nanasato; Kazuo Kato; Naoya Tsuboi; Haruo Hirayama
Related Documents :
21166579 - Is there a role for tamsulosin after shock wave lithotripsy in the treatment of renal a...
21343849 - Asymptomatic same-site recurrent disc herniation after lumbar discectomy: results of a ...
15064629 - Origin of nasal polyps: an endoscopic autopsy study.
21459879 - Undertriage in the manchester triage system: an assessment of severity and options for ...
21395649 - Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treat...
21413949 - Venous ulcer: clinical characteristics and risk factors.
22547249 - Prospective clinical and radiological two-year results after patellofemoral arthroplast...
598099 - Combined biochemical and clinical investigation of chemonucleolysis failures.
18317779 - Complications of endoscopic third ventriculostomy.
Publication Detail:
Type:  Journal Article     Date:  2010-11-22
Journal Detail:
Title:  Pacing and clinical electrophysiology : PACE     Volume:  34     ISSN:  1540-8159     ISO Abbreviation:  Pacing Clin Electrophysiol     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7803944     Medline TA:  Pacing Clin Electrophysiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  296-303     Citation Subset:  IM    
Copyright Information:
©2010, The Authors. Journal compilation ©2010 Wiley Periodicals, Inc.
Affiliation:
Department of Cardiology, Nagoya Daini Red Cross Hospital, Nagoya, Japan Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University, Toyoake, Japan Cardiovascular Internal Medicine, Social Insurance Chukyo Hospital, Nagoya, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analytical determination and pharmacokinetics of major metabolites of carbasalate calcium in broiler...
Next Document:  A case of aborted sudden cardiac death and consequent extreme electrical storm secondary to a metast...